(Press-News.org) "Energy cane" may sound like a trendy sports drink, but it actually is among a new generation of energy crops that could yield up to 5 times more ethanol per acre than corn. They are the topic of the cover story in this week's Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
C&EN Senior Editor Melody M. Bomgardner explains that energy cane is a new, high-fiber variety of sugarcane now being grown in California's Imperial Valley. Scientists bred it specifically as an "energy crop," a genre that includes the giant reed Arundo donax, napier grass, switchgrass and hybrid poplar. Far beyond providing raw material for biobased fuels, such crops also have potential for supplying inexpensive, abundant, sustainable raw materials — "feedstocks" in chemical parlance — like ethylene and propylene. They become ingredients in hundreds of everyday products, ranging from smartphones and televisions to clothing, carpeting and batteries.
The story explains how the biobased fuels and chemicals industry envisions substituting energy crops for oil and natural gas, the traditional sources of such feedstocks. It describes how those efforts are taking on a new sense of urgency because abundant, less-expensive shale gas may make it difficult for biobased feedstocks to compete.
###
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 163,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter Facebook END
A new sense of urgency for energy cane and other energy crops
2013-08-14
ELSE PRESS RELEASES FROM THIS DATE:
Lymph nodes with location memory
2013-08-14
This news release is available in German.
Regulatory T cells (or "Tregs" for short) play a central role in the human immune system: They guide all of the other immune cells and make sure they are tolerant of the body's own cells and harmless foreign substances. How Tregs become Tregs in the first place has been only incompletely understood -- until now. Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, along with their colleagues at the Hannover Medical School (MHH) have recently gleaned important new insights into the workings ...
Pilot study finds ER patients drinking high-octane beer
2013-08-14
Five beer brands – Budweiser, Steel Reserve, Colt 45, Bud Ice and Bud Light – were consumed in the highest quantities by emergency room patients, according to a new pilot study from researchers at The Center on Alcohol Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg School of Public Health. Three of these are "malt liquors" with higher alcohol content than regular beer.
The pilot study, published by Substance Use and Misuse, is the first study of its kind to assess alcohol consumption by brand and type from patients reporting to the emergency department with ...
A genetic answer to the Alzheimer's riddle?
2013-08-14
LEXINGTON, Ky. (Aug. 14, 2013) — What if we could pinpoint a hereditary cause for
Alzheimer's, and intervene to reduce the risk of the disease? We may be closer to that goal, thanks to a team at the University of Kentucky. Researchers affiliated with the UK Sanders-Brown Center on Aging have completed new work in Alzheimer's genetics; the research is detailed in a paper published today in the Journal of Neuroscience.
Emerging evidence indicates that, much like in the case of high cholesterol, some Alzheimer's disease risk is inherited while the remainder is environmental. ...
Chemophobia shouldn't be on the menu
2013-08-14
When it comes to what's for dinner – or breakfast and lunch for that matter-- many people suffer from chemophobia, an irrational fear of natural and synthetic chemicals that pose no risk to our health, a Dartmouth study finds.
Chemistry Professor Gordon Gribble, whose paper appears in the journal Food Security, argues that low doses of chemicals in modern food are inherent, typically harmless and often highly beneficial. He says most people don't know they are routinely exposed to a host of compounds in non-toxic concentrations in what they eat and drink each day. Even ...
Virtual adviser helps older Latino adults get more exercise, Stanford researcher says
2013-08-14
STANFORD, Calif. — When it comes to getting motivated to exercise and do things that are good for our health, sometimes all it takes is a little help from our friends.
This was certainly the case for a group of older, Latino adults in Northern California: They benefited from the advice and encouragement of a virtual friend — a physical-activity adviser named Carmen, a new study reports.
Individuals who participated in an exercise program guided by the virtual adviser had an eight-fold increase in walking compared with those who did not, according to the study, published ...
Rice U. biophysicists zoom in on pore-forming toxin
2013-08-14
HOUSTON -- (Aug. 14, 2013) -- A new study by Rice University biophysicists offers the most comprehensive picture yet of the molecular-level action of melittin, the principal toxin in bee venom. The research could aid in the development of new drugs that use a similar mechanism as melittin's to attack cancer and bacteria.
The study appears this week in the Proceedings of the National Academy of Sciences.
Melittin does its damage by penetrating the outer walls of cells and opening pores that allow the contents of the cell to escape. At low concentrations, melittin forms ...
Ethical issues are often not addressed in national clinical practice guidelines for dementia
2013-08-14
Twelve national dementia clinical practice guidelines included only half of 31 ethical issues the authors had identified as important in patient care, finds a study by Daniel Strech, of Hannover Medical School, Hannover, Germany, and colleagues, published in this week's issue of PLOS Medicine.
The authors identified current national clinical practice guidelines for dementia care published in English or German. They had previously systematically reviewed ethical issues in dementia care and they used thematic text analysis to assess whether and how the ethical issues were ...
Conflicts of interest common among panel members of guidelines that expand disease definitions
2013-08-14
An assessment of expert members of panels making decisions about definitions or diagnostic criteria for common conditions in the US, which were published in guidelines used by physicians and other healthcare professionals caring for patients, found that most members had ties to industry. The assessment was made in a study from Ray Moynihan of Bond University, Queensland, Australia, and colleagues published in this week's issue of PLOS Medicine.
Of the 16 expert panel publications appearing between 2000 and April 2013 that met the authors' criteria of changing disease ...
Cervical cancer screening and treatment are neglected in low- and middle-income countries
2013-08-14
While there have been substantial improvements in mortality rates and an increase in access to reproductive health interventions in low- and middle-income countries (LMICs), the global health community is neglecting prevention, screening, and treatment for cervical cancer in LMICs. These are the conclusions of a new article in PLOS Medicine this week by Ruby Singhrao and colleagues from the University of California San Francisco, San Francisco.
Using a framework including equity and socio-economic, gender, public health, and health services dimensions, the authors propose ...
Study identifies new culprit that may make aging brains susceptible to neurodegenerative diseases
2013-08-14
STANFORD, Calif. —The steady accumulation of a protein in healthy, aging brains may explain seniors' vulnerability to neurodegenerative disorders, a new study by researchers at the Stanford University School of Medicine reports.
The study's unexpected findings could fundamentally change the way scientists think about neurodegenerative disease.
The pharmaceutical industry has spent billions of dollars on futile clinical trials directed at treating Alzheimer's disease by ridding brains of a substance called amyloid plaque. But the new findings have identified another ...